| Ytd | 184.25% | |
| 1y | 46.15% |
| Open | 3.77 | Prev Close | 3.79 | Low | 3.54 | High | 3.89 | Mkt Cap | 16.88M |
| Vol | 81.28K | Avg Vol | 31.51K | EPS | -1.66 | P/E | N/A | Forward P/E | -2.44 |
| Beta | 1.76 | Short Ratio | 0.78 | Inst. Own | 40.41% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 3.64 | 200-d Avg | 2.48 | 1yr Est | 4.00 |
CYCN News
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001755237/000119312526365150/d376250d8k.htm
Cyclerion Therapeutics (NASDAQ:CYCN) reported quarterly losses of $(0.76) per share. This is a 35.71
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan
Major M&A deals this week include: Eli Lilly's $7.8 billion purchase of Centessa Pharmaceuti
NEW YORK, April 2, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Ass
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the merge
GSAT, XOM, CYCN, LLY, INTC were among the stocks seen trending on Wednesday, April 1, 2026.
MILWAUKEE, April 1, 2026 /PRNewswire/ -- Ademi LLP is investigating Cyclerion (NASDAQ: CYCN) for pos
US stocks traded higher with S&P 500 up 1%, Dow up 0.89%, and NASDAQ up 1.56%. Industrials share
Under the deal, the combined company is expected to operate as Korsana Biosciences and trade on the
Cyclerion Therapeutics shares are trading sharply higher Wednesday morning after it announced a merg
Dow up 0.53%, NASDAQ up 1.05%, S&P 500 up 0.62%. Nike shares down 14% despite beating Q3 estimat
Cyclerion Therapeutics, Inc. (CYCN) M&A Call Prepared Remarks Transcript
WALTHAM, Mass.--(BUSINESS WIRE)---- $CYCN--Cyclerion Therapeutics, Inc. (“Cyclerion”) (Nasdaq: CYCN)
–Received Positive Pre-Investigational New Drug (“IND”) Written Feedback from the U.S. Food and Drug
https://s27.q4cdn.com/906368049/files/News/2026/Zacks_SCR_Research_02022026_CYCN_Bautz.pdf
Cyclerion Therapeutics, Inc. (CYCN) Discusses Medsteer Development Collaboration and Updates on Phas
AEVA: 40% | Aeva Technologies' Frequency Modulated Continuous Wave 4D LiDAR Technology Selected
BeyondSpring (NASDAQ: BYSI - Get Free Report) and Cyclerion Therapeutics (NASDAQ: CYCN - Get Free Re
– Cyclerion Strengthens Development of Closed-Loop Anesthetic Platform through Strategic Collaborati
Response Genetics (OTCMKTS:RGDXQ - Get Free Report) and Cyclerion Therapeutics (NASDAQ: CYCN - Get F
Gainers PepGen (NASDAQ: PEPG) stock rose 114.3% to $5.7 during Thursday's regular session. The
Gainers PepGen (NASDAQ: PEPG) shares rose 141.0% to $6.41 during Thursday's pre-market session.
Cyclerion Therapeutics, Inc. - Pre Recorded Special Call Company Participants Regina Graul - CEO, Pr
Cyclerion has entered into a licensing agreement with MIT, securing the intellectual property that w